Patent · US Expired

Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors

US5231081A · kind A · utility

5Cited by

0References

47Claims

0Family size

Inventors

Thomas Stiefel · Stuttgart, DE
Harald Porcher · Stuttgart, DE
Jürgen Markl · Gau-Bischofsheim, DE

Key dates

Filing date	Oct 23, 1991
Grant date	Jul 27, 1993
Priority date	—
Expiry date	Oct 23, 2011

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention deals with the use of hemocyanin, other than keyhole-limpet hemocyanin, arylphorin, or a combination thereof to influence the immune system and for the treatment of tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.